- Home
- ELTX vs JZXN Comparison
ELTX vs JZXN Comparison
Compare ELTX & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- JZXN
- Stock Information
- Founded
- ELTX 2011
- JZXN 2017
- Country
- ELTX United States
- JZXN China
- Employees
- ELTX N/A
- JZXN 33
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- ELTX Health Care
- JZXN Consumer Discretionary
- Exchange
- ELTX Nasdaq
- JZXN Nasdaq
- Market Cap
- ELTX 54.6M
- JZXN 45.5M
- IPO Year
- ELTX 2021
- JZXN 2021
- Fundamental
- Price
- ELTX $8.54
- JZXN $4.37
- Analyst Decision
- ELTX Strong Buy
- JZXN
- Analyst Count
- ELTX 3
- JZXN 0
- Target Price
- ELTX $9.50
- JZXN N/A
- AVG Volume (30 Days)
- ELTX 59.5K
- JZXN 170.6K
- Earning Date
- ELTX 03-28-2025
- JZXN 09-09-2024
- Dividend Yield
- ELTX N/A
- JZXN N/A
- EPS Growth
- ELTX N/A
- JZXN N/A
- EPS
- ELTX N/A
- JZXN N/A
- Revenue
- ELTX N/A
- JZXN $7,597,423.00
- Revenue This Year
- ELTX N/A
- JZXN N/A
- Revenue Next Year
- ELTX N/A
- JZXN N/A
- P/E Ratio
- ELTX N/A
- JZXN N/A
- Revenue Growth
- ELTX N/A
- JZXN 81.94
- 52 Week Low
- ELTX $3.34
- JZXN $1.00
- 52 Week High
- ELTX $11.45
- JZXN $67.60
- Technical
- Relative Strength Index (RSI)
- ELTX 58.77
- JZXN 70.40
- Support Level
- ELTX $7.78
- JZXN $3.53
- Resistance Level
- ELTX $8.23
- JZXN $6.46
- Average True Range (ATR)
- ELTX 0.60
- JZXN 0.74
- MACD
- ELTX -0.15
- JZXN 0.17
- Stochastic Oscillator
- ELTX 55.14
- JZXN 55.05
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.